Skip to main content

LODOCO

Generic: Colchicine Tablets 0.5 mg

Verified·Oct 26, 2026
Manufacturer
AGEPHA
NDC
82867-001
RxCUI
197540
Route
ORAL
ICD-10 indication
I70.9

Affordability Check

How much will you actually pay for LODOCO?

In 30 seconds, see every legitimate way to afford LODOCO — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About LODOCO

What is this medication? Lodoco is a prescription medication that contains a low dose of colchicine, specifically 0.5 mg. It is the first anti-inflammatory drug approved by the FDA to help reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular death, in adults who have established atherosclerotic disease or who are at high risk for developing cardiovascular problems.

The medication works by targeting and reducing the inflammation associated with the buildup of plaque in the arteries, a condition known as atherosclerosis. While many treatments focus on managing cholesterol or blood pressure, Lodoco provides an additional layer of protection by addressing the inflammatory processes that contribute to heart disease complications. It is typically used as a long-term treatment alongside other standard preventative therapies like statins.

Copay & patient assistance

  • Patient Copay Amount: As little as $30 for a 90-day supply for eligible commercially insured patients; as little as $99 per month for uninsured patients.
  • Maximum Annual Benefit Limit: Not Publicly Available.
  • Core Eligibility Restrictions: Offer available to eligible patients with commercial insurance; Patient Assistance Program (no-cost option) is based on specific income and insurance criteria; prescriptions must be processed through BlinkRx or Marley.
  • RxBIN, PCN, and Group numbers: Not Publicly Available.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How LODOCO appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

0%

19 of 5,499 plans

Most common tier

Tier 4

On 86% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)2
14%
Tier 4 (non-preferred brand)12
86%

Step therapy: 0% of formularies

Quantity limits: 71% of formularies

Coverage breadth: 14 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.